未登录

B

Bingnan Yin

University of Southern California

H指数:12

被引数:1,136

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ACE2-dependent and -independent SARS-CoV-2 entries dictate viral replication and inflammatory response during infection

NATURE CELL BIOLOGY

IF19.1

2024-03-216

PRE

Addendum: USP3 plays a critical role in the induction of innate immune tolerance

IF6.2

2024-03-010

OA

USP3 plays a critical role in the induction of innate immune tolerance

IF6.2

2023-11-164

OA

Development of a TCR-like antibody and chimeric antigen receptor against NY-ESO-1/HLA-A2 for cancer immunotherapy

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2022-03-2532

OAAI

Pharmacological inhibition of fatty acid synthesis blocks SARS-CoV-2 replication

NATURE METABOLISM

IF20.8

2021-09-2783

OAAI

Beclin 2 negatively regulates innate immune signaling and tumor development

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2020-08-3118

OA

JMJD3 regulates CD4+ T cell trafficking by targeting actin cytoskeleton regulatory gene Pdlim4

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2019-09-3018

OA

Downregulation of Human Endogenous Retrovirus Type K (HERV-K) Viral env RNA in Pancreatic Cancer Cells Decreases Cell Proliferation and Tumor Growth (vol 23, pg 5892, 2017)

CLINICAL CANCER RESEARCH

IF10.2

2019-05-012

OAAI

Downregulation of Human Endogenous Retrovirus Type K (HERV-K) Viral env RNA in Pancreatic Cancer Cells Decreases Cell Proliferation and Tumor Growth

CLINICAL CANCER RESEARCH

IF10.2

2017-10-0191

OAAI

Cytotoxicity of Human Endogenous Retrovirus K-Specific T Cells toward Autologous Ovarian Cancer Cells

CLINICAL CANCER RESEARCH

IF10.2

2015-01-1479

OAAI

Human endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early-stage breast cancer

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2013-11-2099

OA

Immunotherapeutic Potential of Anti-Human Endogenous Retrovirus-K Envelope Protein Antibodies in Targeting Breast Tumors

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE

IF7.2

2012-01-12131

OAAI